OTCMKTS:SPHS Sophiris Bio (SPHS) Stock Price, News & Analysis → This is the ONLY AI story you should be worried about (From InvestorPlace) (Ad) Free SPHS Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket Capitalization$4,000.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Sophiris Bio alerts: Email Address Ad Stansberry ResearchDo NOT read if you believe in “woke” politicsI have to warn you, however: This CEO of a publicly traded company is not afraid to mince words. Many on Wall Street have refused to work with him.Everything you need to know is posted on our website here. About Sophiris Bio Stock (OTCMKTS:SPHS)Sophiris Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products for the treatment of urological diseases. The company was founded by James L. Heppell in May 2003 and is headquartered in La Jolla, CA.Read More Ad Stansberry ResearchDo NOT read if you believe in “woke” politicsI have to warn you, however: This CEO of a publicly traded company is not afraid to mince words. Many on Wall Street have refused to work with him.Everything you need to know is posted on our website here. SPHS Stock News HeadlinesOctober 13, 2023 | usnews.comBest Louisiana High SchoolsJuly 20, 2023 | finance.yahoo.comBLTE - Belite Bio, IncMay 7, 2024 | Colonial Metals (Ad)The Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.June 12, 2023 | forbes.comBio-Reference LaboratoriesMarch 20, 2023 | finance.yahoo.comSophiris Bio Inc. Registered Sh (BFF1.SG)January 25, 2023 | msn.comSPHS Indoor Track Wins Girls Blue Division at GMC ChampionshipsJanuary 17, 2023 | msn.comSPHS Weekly Sports Recap: All Sports Notch Big WinsSee More Headlines Receive SPHS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sophiris Bio and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/09/2019Today5/06/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolOTCMKTS:SPHS CUSIPN/A CIK1563855 Webwww.sophirisbio.com Phone(858) 777-1760FaxN/AEmployees2,018Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares35,550,000Free FloatN/AMarket Cap$4,000.00 OptionableNot Optionable Beta1.94 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesRandall E. WoodsPresident & Chief Executive OfficerPeter T. SloverChief Financial & Accounting OfficerKey CompetitorsEndonovo TherapeuticsOTCMKTS:ENDVDImagenetixOTCMKTS:IAGXOncoSec MedicalNASDAQ:ONCSQRegeneRx BiopharmaceuticalsOTCMKTS:RGRXSkystar Bio-PharmaceuticalOTCMKTS:SKBIView All Competitors SPHS Stock Analysis - Frequently Asked Questions How were Sophiris Bio's earnings last quarter? Sophiris Bio, Inc. (OTCMKTS:SPHS) released its quarterly earnings results on Thursday, May, 9th. The company reported ($0.08) EPS for the quarter, topping the consensus estimate of ($0.10) by $0.02. How do I buy shares of Sophiris Bio? Shares of SPHS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:SPHS) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersBiden’s $374B Giveaway Into This SectorDTIAI “wealth window” is closing June 25thParadigm PressThe asset beating inflation by 4xColonial MetalsCould Your Accounts Be Frozen?Allegiance GoldHe Is Giving Away BitcoinCrypto Swap ProfitsElon to Transform U.S. Economy? Porter & CompanyElon Musk Secret Crypto Plot ExposedCrypto 101 MediaMissed NVDA? Buy this AI stock NOWChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sophiris Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
